Inrad Optics Inc (INRD) 0.2200 $INRD
Inrad Optics, Inc. Reports First Quarter 2014 Financial Results
PR Newswire - Wed May 21, 12:37PM CDT
Inrad Optics, Inc. (OTCBB: INRD) has reported its consolidated financial results for the three months ended March 31, 2014.
FY 2013 Financial Results Released By Inrad Optics, Inc.
PR Newswire - Tue Apr 01, 4:34PM CDT
Inrad Optics, Inc. (the "Company"
(OTC Bulletin Board: INRD) has released its consolidated financial results for the year ended December 31, 2013.
MediPoint: Biopsy Devices - South America Analysis and Market Forecasts
M2 - Fri Mar 14, 3:31AM CDT
Research and Markets (http://www.researchandmarkets.com/research/hj94jl/medipoint_biopsy) has announced the addition of the "MediPoint: Biopsy Devices - South America Analysis and Market Forecasts" report to their offering. Cancer is the uncontrolled growth of abnormal cells in the body. It can affect numerous organs and tissues of the body. When a patient is suspected of having a particular type of cancer, a biopsy procedure is performed to extract a target tissue sample for histological analysis. This intervention typically provides a definitive cancer diagnosis for the patient. Given that these procedures play such an important role in the diagnostic pathway for various cancers, medical device manufacturers have worked to develop biopsy devices that maximize the volume and quality of the tissue samples, as well as decrease their negative impact on the patient's body. As seen with other medical device markets, less invasive biopsy techniques have entered the market and have established a new gold standard in many global regions. A similar pattern in biopsy procedure volumes for the cancer indications covered in this report can be observed in the major South American market of Brazil as in the major European markets previously discussed. Both prostate and breast biopsy procedures account for the largest portion of the overall market. Scope - An overview of biopsy devices, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines. - Annualized SA biopsy devices market revenue and future forecasts from 2010 to 2012, forecast for 7 years to 2019. - Investigation of current and future market competition for biopsy devices. - Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events. - Competitor assessment including device approval analysis and device sales forecasts. - Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast. - Analysis of unmet needs within the market and opportunities for future players. Key Topics Covered: List of Tables List of Figures Introduction Industry Overview Unmet Needs Market Opportunity Analysis Market Drivers and Barriers Competitive Assessment Pipeline Assessment Clinical Trial Analysis Current and Future Players Market Outlook Appendix Companies Mentioned Argon Medical Devices Boston Scientific Cardinal Health CareFusion Corporation Cook Medical C. R. Bard Devicor Medical Products DTR Medical Gallini Medical Devices Hologic INRAD Intact Medical Corporation TSK Laboratory For more information visit http://www.researchandmarkets.com/research/hj...int_biopsy About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
MediPoint: Biopsy Devices - APAC Analysis and Market Forecasts
M2 - Thu Mar 13, 4:32AM CDT
Research and Markets (http://www.researchandmarkets.com/research/wl9hj7/medipoint_biopsy) has announced the addition of the "MediPoint: Biopsy Devices - APAC Analysis and Market Forecasts" report to their offering. Cancer is the uncontrolled growth of abnormal cells in the body. It can affect numerous organs and tissues of the body. When a patient is suspected of having a particular type of cancer, a biopsy procedure is performed to extract a target tissue sample for histological analysis. This intervention typically provides a definitive cancer diagnosis for the patient. Given that these procedures play such an important role in the diagnostic pathway for various cancers, medical device manufacturers have worked to develop biopsy devices that maximize the volume and quality of the tissue samples, as well as decrease their negative impact on the patient's body. As seen with other medical device markets, less invasive biopsy techniques have entered the market and have established a new gold standard in many global regions. Countries in the Asia Pacific (APAC) region such as Japan and China and the South American country of Brazil will have growth rates that are more than double the global CAGR. This is primarily due to the increased market access of each country's population to healthcare resources and the increased adoption of more expensive core needle biopsy devices over fine needle aspiration devices. Scope - An overview of biopsy devices, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines. - Annualized APAC biopsy devices market revenue and future forecasts from 2010 to 2012, forecast for 7 years to 2019. - Investigation of current and future market competition for biopsy devices. - Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events. - Competitor assessment including device approval analysis and device sales forecasts. - Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast. - Analysis of unmet needs within the market and opportunities for future players. Key Topics Covered: List of Tables List of Figures Introduction Industry Overview Unmet Needs Market Opportunity Analysis Market Drivers and Barriers Competitive Assessment Pipeline Assessment Clinical Trial Analysis Current and Future Players Market Outlook Appendix Companies Mentioned Argon Medical Devices Boston Scientific Cardinal Health CareFusion Corporation Cook Medical C. R. Bard Devicor Medical Products DTR Medical Gallini Medical Devices Hologic INRAD Intact Medical Corporation TSK Laboratory For more information visit http://www.researchandmarkets.com/research/wl...int_biopsy About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
MediPoint: Biopsy Devices - US Analysis and Market Forecasts Research Report
M2 - Wed Mar 12, 3:20AM CDT
Research and Markets (http://www.researchandmarkets.com/research/66ts7p/medipoint_biopsy) has announced the addition of the "MediPoint: Biopsy Devices - US Analysis and Market Forecasts" report to their offering. Cancer is the uncontrolled growth of abnormal cells in the body. It can affect numerous organs and tissues of the body. When a patient is suspected of having a particular type of cancer, a biopsy procedure is performed to extract a target tissue sample for histological analysis. This intervention typically provides a definitive cancer diagnosis for the patient. Given that these procedures play such an important role in the diagnostic pathway for various cancers, medical device manufacturers have worked to develop biopsy devices that maximize the volume and quality of the tissue samples, as well as decrease their negative impact on the patient's body. As seen with other medical device markets, less invasive biopsy techniques have entered the market and have established a new gold standard in many global regions. While the global biopsy devices market is expected to see growth over the forecast period, there are several barriers that are dampening the intervention's potential adoption levels. Notably in the US, reimbursement for image guided breast biopsies has undergone some restructuring. The 2014 Medicare Fee Schedule Final Rule imposed drastic reimbursement cuts for these procedures which will have a significant effect on the adoption of more expensive vacuum assisted biopsy (VAB) devices. Scope - An overview of biopsy devices, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines. - Annualized the US biopsy devices market revenue and future forecasts from 2010 to 2012, forecast for 7 years to 2019. - Investigation of current and future market competition for biopsy devices - Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events. - Competitor assessment including device approval analysis and device sales forecasts. - Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast. Companies Mentioned Argon Medical Devices Boston Scientific Cardinal Health CareFusion Corporation Cook Medical C. R. Bard Devicor Medical Products DTR Medical Gallini Medical Devices Hologic INRAD Intact Medical Corporation TSK Laboratory For more information visit http://www.researchandmarkets.com/research/66...int_biopsy About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Optical Coatings Market: Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
M2 - Fri Mar 07, 3:25AM CST
Research and Markets (http://www.researchandmarkets.com/research/sfxss9/optical_coatings) has announced the addition of the "Optical Coatings Market: Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019" report to their offering. 'Optical Coatings Market (Anti-Reflective Coatings, Filter coatings, Transparent Electrodes, Reflective Coatings and Others) For Electronics, Defense/security, Infrastructure, Solar and Others Applications: Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019' The report analyses the optical coatings market. For an insightful understanding, analysis and forecast have been provided for the time period ranging from 2013 to 2019. The forecasts are on the basis of volume (kilo tons) and revenue (USD million) for both global and regional levels. In-depth analysis of the various factors driving and restraining growth of the optical coatings industry has been included. A thorough analysis of the prevailing and expected growth opportunities in the industry has been included in decision-making. The value chain analysis comprises of a detailed evaluation of the roles of various entities involved in the optical coatings industry from raw material suppliers to the end users. In addition, Porter's five forces model has been used to determine the degree of competition in the industry during the forecast period. Furthermore, market attractiveness analysis has been done to analyze which application segments are expected to be lucrative during the forecast period on the basis of their market size and growth rate. The optical coatings market has been segmented on the basis of product and application. The segments have been analyzed and forecast for a time period ranging from 2013 to 2019. The forecast is on the basis of volume (kilo tons) and revenue (USD million) for both regional and global level based on current and expected trends of the industry. Regionally, the market has been segmented into North America, Europe, Asia Pacific and Rest of the World (RoW), and the demand has been analyzed and forecast based on current trends for a period of six years, ranging from 2013 to 2019. The report also covers profiles of the leading companies in the optical coating industry. A detailed analysis of the market shares of the major players has been included. Company profiles of companies such as PPG industries, 3M Precision Optics, OphirOptronics Ltd., and certain other companies has been included. The company profile encompasses various attributes of the companies including company overview, financial overview, SWOT analysis, business strategies and recent developments. Key Topics Covered: Preface Executive Summary Optical Coatings - Industry Analysis Optical Coatings Market - Product Segment Analysis Optical Coatings Market: Application Analysis Optical Coatings Market: Regional Analysis Company Profiles List of Figures List of Tables Companies Mentioned - 3M Precision Optics - Abrisa Technologies. - Denton Vacuum, LLC - Inrad Optics - JDSU - Janos Technology, Inc. - Newport Corporation - Ophir Optronics, Ltd. - Optical Coatings Japan - PPG Industries For more information visit http://www.researchandmarkets.com/research/sf...l_coatings About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Global Biopsy Devices Market Value to Grow Moderately by 2019, with Emerging Countries Increasing their Shares
M2 - Wed Mar 05, 3:50AM CST
Research and Markets (http://www.researchandmarkets.com/research/qtvmxw/medipoint_biopsy) has announced the addition of the "MediPoint: Biopsy Devices - Global Analysis and Market Forecasts" report to their offering. The global biopsy devices market value will increase at a modest rate over the coming years, climbing from $506.4 million in 2013 to $602.4 million by 2019, at a Compound Annual Growth Rate (CAGR) of 2.93% The biopsy devices market in emerging economies, such as China, India and Brazil, will increase at much higher CAGRS than the global rate, reaching shares of 24%, 10% and 6% by 2019, respectively. Despite the modest global growth, several barriers are dampening the potential adoption of biopsy devices within a number of markets. Notably in the US, reimbursement for image-guided breast biopsies has undergone drastic cuts, which The authors expects will have a significant effect on the adoption of more expensive vacuum-assisted biopsy (VAB) devices. Joseph Gregory, the analyst covering Surgical Devices, says: Additionally, routine screening for prostate cancer and breast cancer has come under scrutiny, as sophisticated clinical trials reveal that these interventions have a minimal impact on the cancer related mortality. This is a long-term setback for the adoption of biopsy devices in diagnosing these cancers, given that these criticisms could curb adoption of routine screening. While these challenges are likely to affect the biopsy devices market, The authors believes that current and future players can still position themselves to obtain a competitive advantage. The major European countries have general mass-screening programs for breast cancer detection and will be increasing their adoption of VAB devices over the forecast period. Additionally, the emerging economies are increasing their access to healthcare resources and showing a preference for more expensive core needle biopsy devices over fine needle aspiration devices, Gregory concludes. This report and forecast focuses on the adoption patterns of surgical biopsies, fine needle aspiration (FNA) devices, core needle biopsy (CNB) devices, and vacuum-assisted biopsy (VAB) devices in the diagnosis of breast, prostate, lung, liver, and thyroid cancers. Countries covered include the US, France, Germany, Italy, Spain, the UK, Japan, Brazil, China, and India. Key Topics Covered: List of Tables List of Figures Introduction Industry Overview Unmet Needs Market Opportunity Analysis Market Drivers and Barriers Competitive Assessment Pipeline Assessment Clinical Trial Analysis Current and Future Players Market Outlook Appendix Companies Mentioned Argon Medical Devices Boston Scientific Cardinal Health CareFusion Corporation Cook Medical C. R. Bard Devicor Medical Products DTR Medical Gallini Medical Devices Hologic INRAD Intact Medical Corporation TSK Laboratory For more information visit http://www.researchandmarkets.com/research/qt...int_biopsy About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
MediPoint: Biopsy Devices - Current and Future Players Report
M2 - Tue Mar 04, 2:34AM CST
Research and Markets (http://www.researchandmarkets.com/research/t5nxz6/medipoint_biopsy) has announced the addition of the "MediPoint: Biopsy Devices - Current and Future Players" report to their offering. Cancer is the uncontrolled growth of abnormal cells in the body. It can affect numerous organs and tissues of the body. When a patient is suspected of having a particular type of cancer, a biopsy procedure is performed to extract a target tissue sample for histological analysis. This intervention typically provides a definitive cancer diagnosis for the patient. Given that these procedures play such an important role in the diagnostic pathway for various cancers, medical device manufacturers have worked to develop biopsy devices that maximize the volume and quality of the tissue samples, as well as decrease their negative impact on the patient's body. As seen with other medical device markets, less invasive biopsy techniques have entered the market and have established a new gold standard in many global regions. The report identifies and analyzes the key companies shaping and driving the global Biopsy Devices market. The report provides insight into the competitive Biopsy Devices landscape, including new companies entering the market and pipeline products in development. This report is built using data and information sourced from proprietary databases, secondary sources and primary research interviews and survey with leading cardiologists, with in-house analysis conducted by Our team of industry experts. Scope - Investigation of current and future market competition for Biopsy Devices. - Competitor assessment including device approval analysis. - Coverage of key market players and company profiles including business description, financial overview and SWOT analysis. - Strategic assessment of the device sector through market impact analysis, future market scenario and company analysis. - Direct quotes from Key Opinion Leaders (KOL) as well as cardiologists using Biopsy Devices devices in clinical practice. Key Topics Covered: List of Tables List of Figures Introduction Competitive Assessment Pipeline Assessment Current and Future Players Appendix Companies Mentioned Argon Medical Devices Boston Scientific Cardinal Health CareFusion Corporation Cook Medical C. R. Bard Devicor Medical Products DTR Medical Gallini Medical Devices Hologic INRAD Intact Medical Corporation TSK Laboratory For more information visit http://www.researchandmarkets.com/research/t5...int_biopsy About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
2013 Report on the International Biopsy Devices Market - Global Forecasts to 2018
M2 - Mon Jan 06, 6:20AM CST
Research and Markets (http://www.researchandmarkets.com/research/s3fbcm/biopsy_devices) has announced the addition of the "2013 Report on the International Biopsy Devices Market - Global Forecasts to 2018" report to their offering. For the purpose of this research, the international biopsy device market has also been segmented geographically into four regions, namely, North America, Europe, Asia and Rest of the World (RoW), and the respective market sizes and forecasts have been provided for each of these regions. A detailed qualitative analysis of the factors responsible for driving and restraining growth of the global biopsy devices market, and future opportunities is provided in the market overview section. This section also features a detailed market attractiveness analysis and Porter's five force analysis for the biopsy devices market. The competitive landscape section includes market share analysis of all the leading players in this market, for the year 2011. Some of the major players profiled in this report include Angiotech, C R Bard Inc., CareFusion Corporation, Devicor Medical Products Inc. and Hologic Inc. Key Topics Covered: 1 Preface 1.1 Report Description 1.2 Market Segmentation 1.3 Research Methodology 2 Executive Summary 3 Market Overview 3.1 Introduction 3.2 Market Drivers 3.3 Market Restraints 3.4 Market Opportunities 3.5 Porter's Five Forces Analysis 3.6 Market Attractiveness Analysis 4 Biopsy Devices Market, By Product Types 4.1 Introduction 4.2 Comparative Analysis: Biopsy Devices Market, By Product Types, 2011 & 2018 (Value %) 4.3 Needle-Based Biopsy Guns 4.4 Biopsy Needles 4.5 Biopsy Forceps 4.6 Biopsy Guidance Systems 4.7 Others 5 Biopsy Devices Market, By Geography 5.1 Comparative Analysis: Biopsy Devices Market, By Geography, 2011 & 2018 (Value %) 5.2 North America 5.3 Europe 5.4 Asia 5.5 Rest of the World 6 Competitive Landscape 7 Recommendations 8 Company Profiles Companies Mentioned: - Angiotech - Cardinal Health Inc. - Carefusion Corporation - C. R. BARD, Inc. - Devicor Medical Products, Inc. - DTR Medical - Hologic, Inc. - INRAD, Inc. - UK Biopsy For more information visit http://www.researchandmarkets.com/research/s3...sy_devices
IBC at SPIE Optics + Photonics 2013 Conference: White Paper Confirms Significant Cost Savings Using Beralcast(R) High Performance Alloys
Marketwire - Tue Sep 10, 8:03AM CDT
IBC Advanced Alloys Corp. (TSX VENTURE: IB)(OTCQX: IAALF) ("IBC" or the "Company" released a white paper and presented a preliminary analysis of IBC's proprietary Beralcast(R) alloys as a cost-effective high performance alloy solution for advanced optical applications at the recent SPIE Optics + Photonics 2013 Conference in San Diego. The white paper confirmed that significant cost savings are potentially achievable with the mirror design selected for the study.
Inrad Optics, Inc. Reports Financial Results For Second Quarter And Six Months 2013
PR Newswire - Mon Aug 19, 7:00AM CDT
Inrad Optics, Inc. (OTC Bulletin Board: INRD) has reported its consolidated financial results for its second quarter and six months ended June 30, 2013.
IV Fluid Transfer Devices Report - Products, Players, Markets and Opportunities
M2 - Wed Jun 26, 3:38AM CDT
Research and Markets (http://www.researchandmarkets.com/research/fnpmtc/iv_fluid_transfer) has announced the addition of the "IV Fluid Transfer Devices Products, Players, Markets and Opportunities" report to their offering. Intravenous drug administration is one of the most common therapeutic procedures that patients in a hospital setting are likely to receive. Yet the lack of standardization among the various components, elements and steps that a caregiver must navigate to successfully execute a drug intravenously have - according to several recent studies - contributed to medication errors and risks to patient safety. IV drug administration was once provided to patients only in clinical settings. However, technology developments and a greater emphasis on cost containment over the last 30 years have prompted a shift to providing this therapy in alternate settings, including the home. Highlights: - Analyzes the global market for IV fluid transfer devices market segments, and assesses the probable market
Inrad Optics Installs New Plasma Assisted Deposition System
PR Newswire - Tue Apr 23, 10:55AM CDT
Inrad Optics, Inc. (OTBB: INRD) has advanced its thin film coating capabilities with the installation of a new plasma assisted e-beam vacuum deposition system. The new coating system employs high-density plasma technology to dramatically enhance the quality of thin films by improving a wide variety of mechanical and optical properties. Its large 96-inch chamber also significantly increases Inrad Optics' capacity and allows the company to handle parts up to 1 meter in diameter.
Biopsy Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018
M2 - Thu Apr 04, 8:34AM CDT
Research and Markets (http://www.researchandmarkets.com/research/5smfv8/biopsy_devices) has announced the addition of the "Biopsy Devices Market (Disposable & Reusable Needles, Hot & Cold Forceps, Needle-based Biopsy Guns, VAB, CNB, FNAB Devices, Guidance Systems) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018" report to their offering. Biopsy devices are growing in importance due to the increasing global incidence of cancer and the growing willingness of patients to spend money on these medical procedures. This report studies the market for biopsy devices in five different product segments, namely, needle-based biopsy guns, biopsy needles, biopsy forceps, biopsy guidance systems and other biopsy devices. Each of these segments has been further divided into sub-segments by type. Market size estimates and forecasts for the period 2010 to 2018 have been given for each of the segments and sub-segments, in terms of USD million, using 2011 as the base year. The CAGR (%) of eac
Inrad Optics, Inc. Announces FY 2012 Financial Results
PR Newswire - Wed Apr 03, 3:18PM CDT
Inrad Optics, Inc. (the "Company" (OTC Bulletin Board: INRD) has released its consolidated financial results for the year ended December 31, 2012.
Inrad Optics, Inc. Announces Reduction In Work-force
PR Newswire - Thu Mar 07, 12:30PM CST
Optical component and crystalline device manufacturer Inrad Optics, Inc. (OTCBB: INRD) announced a combined work-force reduction of eight employees at its Northvale, NJ and Sarasota, FL production facilities effective March 1, 2013. This represents a reduction of approximately 9%. The Company has undertaken these steps to reduce costs and improve efficiencies within the organization. The move is expected to save the Company $658,000 annually including estimated fringe benefit costs and additional savings from reduced work hours for selected employees. This excludes one-time severance and accrued vacation payments to terminated employees of approximately $105,000 which the Company expects to pay in the first quarter ending March 31, 2013.
Inrad Optics, Inc. Reports First Quarter 2014 Financial Results
PR Newswire - Wed May 21, 12:37PM CDT
Inrad Optics, Inc. (OTCBB: INRD) has reported its consolidated financial results for the three months ended March 31, 2014.
FY 2013 Financial Results Released By Inrad Optics, Inc.
PR Newswire - Tue Apr 01, 4:34PM CDT
Inrad Optics, Inc. (the "Company"
(OTC Bulletin Board: INRD) has released its consolidated financial results for the year ended December 31, 2013. MediPoint: Biopsy Devices - South America Analysis and Market Forecasts
M2 - Fri Mar 14, 3:31AM CDT
Research and Markets (http://www.researchandmarkets.com/research/hj94jl/medipoint_biopsy) has announced the addition of the "MediPoint: Biopsy Devices - South America Analysis and Market Forecasts" report to their offering. Cancer is the uncontrolled growth of abnormal cells in the body. It can affect numerous organs and tissues of the body. When a patient is suspected of having a particular type of cancer, a biopsy procedure is performed to extract a target tissue sample for histological analysis. This intervention typically provides a definitive cancer diagnosis for the patient. Given that these procedures play such an important role in the diagnostic pathway for various cancers, medical device manufacturers have worked to develop biopsy devices that maximize the volume and quality of the tissue samples, as well as decrease their negative impact on the patient's body. As seen with other medical device markets, less invasive biopsy techniques have entered the market and have established a new gold standard in many global regions. A similar pattern in biopsy procedure volumes for the cancer indications covered in this report can be observed in the major South American market of Brazil as in the major European markets previously discussed. Both prostate and breast biopsy procedures account for the largest portion of the overall market. Scope - An overview of biopsy devices, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines. - Annualized SA biopsy devices market revenue and future forecasts from 2010 to 2012, forecast for 7 years to 2019. - Investigation of current and future market competition for biopsy devices. - Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events. - Competitor assessment including device approval analysis and device sales forecasts. - Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast. - Analysis of unmet needs within the market and opportunities for future players. Key Topics Covered: List of Tables List of Figures Introduction Industry Overview Unmet Needs Market Opportunity Analysis Market Drivers and Barriers Competitive Assessment Pipeline Assessment Clinical Trial Analysis Current and Future Players Market Outlook Appendix Companies Mentioned Argon Medical Devices Boston Scientific Cardinal Health CareFusion Corporation Cook Medical C. R. Bard Devicor Medical Products DTR Medical Gallini Medical Devices Hologic INRAD Intact Medical Corporation TSK Laboratory For more information visit http://www.researchandmarkets.com/research/hj...int_biopsy About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
MediPoint: Biopsy Devices - APAC Analysis and Market Forecasts
M2 - Thu Mar 13, 4:32AM CDT
Research and Markets (http://www.researchandmarkets.com/research/wl9hj7/medipoint_biopsy) has announced the addition of the "MediPoint: Biopsy Devices - APAC Analysis and Market Forecasts" report to their offering. Cancer is the uncontrolled growth of abnormal cells in the body. It can affect numerous organs and tissues of the body. When a patient is suspected of having a particular type of cancer, a biopsy procedure is performed to extract a target tissue sample for histological analysis. This intervention typically provides a definitive cancer diagnosis for the patient. Given that these procedures play such an important role in the diagnostic pathway for various cancers, medical device manufacturers have worked to develop biopsy devices that maximize the volume and quality of the tissue samples, as well as decrease their negative impact on the patient's body. As seen with other medical device markets, less invasive biopsy techniques have entered the market and have established a new gold standard in many global regions. Countries in the Asia Pacific (APAC) region such as Japan and China and the South American country of Brazil will have growth rates that are more than double the global CAGR. This is primarily due to the increased market access of each country's population to healthcare resources and the increased adoption of more expensive core needle biopsy devices over fine needle aspiration devices. Scope - An overview of biopsy devices, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines. - Annualized APAC biopsy devices market revenue and future forecasts from 2010 to 2012, forecast for 7 years to 2019. - Investigation of current and future market competition for biopsy devices. - Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events. - Competitor assessment including device approval analysis and device sales forecasts. - Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast. - Analysis of unmet needs within the market and opportunities for future players. Key Topics Covered: List of Tables List of Figures Introduction Industry Overview Unmet Needs Market Opportunity Analysis Market Drivers and Barriers Competitive Assessment Pipeline Assessment Clinical Trial Analysis Current and Future Players Market Outlook Appendix Companies Mentioned Argon Medical Devices Boston Scientific Cardinal Health CareFusion Corporation Cook Medical C. R. Bard Devicor Medical Products DTR Medical Gallini Medical Devices Hologic INRAD Intact Medical Corporation TSK Laboratory For more information visit http://www.researchandmarkets.com/research/wl...int_biopsy About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
MediPoint: Biopsy Devices - US Analysis and Market Forecasts Research Report
M2 - Wed Mar 12, 3:20AM CDT
Research and Markets (http://www.researchandmarkets.com/research/66ts7p/medipoint_biopsy) has announced the addition of the "MediPoint: Biopsy Devices - US Analysis and Market Forecasts" report to their offering. Cancer is the uncontrolled growth of abnormal cells in the body. It can affect numerous organs and tissues of the body. When a patient is suspected of having a particular type of cancer, a biopsy procedure is performed to extract a target tissue sample for histological analysis. This intervention typically provides a definitive cancer diagnosis for the patient. Given that these procedures play such an important role in the diagnostic pathway for various cancers, medical device manufacturers have worked to develop biopsy devices that maximize the volume and quality of the tissue samples, as well as decrease their negative impact on the patient's body. As seen with other medical device markets, less invasive biopsy techniques have entered the market and have established a new gold standard in many global regions. While the global biopsy devices market is expected to see growth over the forecast period, there are several barriers that are dampening the intervention's potential adoption levels. Notably in the US, reimbursement for image guided breast biopsies has undergone some restructuring. The 2014 Medicare Fee Schedule Final Rule imposed drastic reimbursement cuts for these procedures which will have a significant effect on the adoption of more expensive vacuum assisted biopsy (VAB) devices. Scope - An overview of biopsy devices, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines. - Annualized the US biopsy devices market revenue and future forecasts from 2010 to 2012, forecast for 7 years to 2019. - Investigation of current and future market competition for biopsy devices - Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events. - Competitor assessment including device approval analysis and device sales forecasts. - Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast. Companies Mentioned Argon Medical Devices Boston Scientific Cardinal Health CareFusion Corporation Cook Medical C. R. Bard Devicor Medical Products DTR Medical Gallini Medical Devices Hologic INRAD Intact Medical Corporation TSK Laboratory For more information visit http://www.researchandmarkets.com/research/66...int_biopsy About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Optical Coatings Market: Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
M2 - Fri Mar 07, 3:25AM CST
Research and Markets (http://www.researchandmarkets.com/research/sfxss9/optical_coatings) has announced the addition of the "Optical Coatings Market: Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019" report to their offering. 'Optical Coatings Market (Anti-Reflective Coatings, Filter coatings, Transparent Electrodes, Reflective Coatings and Others) For Electronics, Defense/security, Infrastructure, Solar and Others Applications: Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019' The report analyses the optical coatings market. For an insightful understanding, analysis and forecast have been provided for the time period ranging from 2013 to 2019. The forecasts are on the basis of volume (kilo tons) and revenue (USD million) for both global and regional levels. In-depth analysis of the various factors driving and restraining growth of the optical coatings industry has been included. A thorough analysis of the prevailing and expected growth opportunities in the industry has been included in decision-making. The value chain analysis comprises of a detailed evaluation of the roles of various entities involved in the optical coatings industry from raw material suppliers to the end users. In addition, Porter's five forces model has been used to determine the degree of competition in the industry during the forecast period. Furthermore, market attractiveness analysis has been done to analyze which application segments are expected to be lucrative during the forecast period on the basis of their market size and growth rate. The optical coatings market has been segmented on the basis of product and application. The segments have been analyzed and forecast for a time period ranging from 2013 to 2019. The forecast is on the basis of volume (kilo tons) and revenue (USD million) for both regional and global level based on current and expected trends of the industry. Regionally, the market has been segmented into North America, Europe, Asia Pacific and Rest of the World (RoW), and the demand has been analyzed and forecast based on current trends for a period of six years, ranging from 2013 to 2019. The report also covers profiles of the leading companies in the optical coating industry. A detailed analysis of the market shares of the major players has been included. Company profiles of companies such as PPG industries, 3M Precision Optics, OphirOptronics Ltd., and certain other companies has been included. The company profile encompasses various attributes of the companies including company overview, financial overview, SWOT analysis, business strategies and recent developments. Key Topics Covered: Preface Executive Summary Optical Coatings - Industry Analysis Optical Coatings Market - Product Segment Analysis Optical Coatings Market: Application Analysis Optical Coatings Market: Regional Analysis Company Profiles List of Figures List of Tables Companies Mentioned - 3M Precision Optics - Abrisa Technologies. - Denton Vacuum, LLC - Inrad Optics - JDSU - Janos Technology, Inc. - Newport Corporation - Ophir Optronics, Ltd. - Optical Coatings Japan - PPG Industries For more information visit http://www.researchandmarkets.com/research/sf...l_coatings About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Global Biopsy Devices Market Value to Grow Moderately by 2019, with Emerging Countries Increasing their Shares
M2 - Wed Mar 05, 3:50AM CST
Research and Markets (http://www.researchandmarkets.com/research/qtvmxw/medipoint_biopsy) has announced the addition of the "MediPoint: Biopsy Devices - Global Analysis and Market Forecasts" report to their offering. The global biopsy devices market value will increase at a modest rate over the coming years, climbing from $506.4 million in 2013 to $602.4 million by 2019, at a Compound Annual Growth Rate (CAGR) of 2.93% The biopsy devices market in emerging economies, such as China, India and Brazil, will increase at much higher CAGRS than the global rate, reaching shares of 24%, 10% and 6% by 2019, respectively. Despite the modest global growth, several barriers are dampening the potential adoption of biopsy devices within a number of markets. Notably in the US, reimbursement for image-guided breast biopsies has undergone drastic cuts, which The authors expects will have a significant effect on the adoption of more expensive vacuum-assisted biopsy (VAB) devices. Joseph Gregory, the analyst covering Surgical Devices, says: Additionally, routine screening for prostate cancer and breast cancer has come under scrutiny, as sophisticated clinical trials reveal that these interventions have a minimal impact on the cancer related mortality. This is a long-term setback for the adoption of biopsy devices in diagnosing these cancers, given that these criticisms could curb adoption of routine screening. While these challenges are likely to affect the biopsy devices market, The authors believes that current and future players can still position themselves to obtain a competitive advantage. The major European countries have general mass-screening programs for breast cancer detection and will be increasing their adoption of VAB devices over the forecast period. Additionally, the emerging economies are increasing their access to healthcare resources and showing a preference for more expensive core needle biopsy devices over fine needle aspiration devices, Gregory concludes. This report and forecast focuses on the adoption patterns of surgical biopsies, fine needle aspiration (FNA) devices, core needle biopsy (CNB) devices, and vacuum-assisted biopsy (VAB) devices in the diagnosis of breast, prostate, lung, liver, and thyroid cancers. Countries covered include the US, France, Germany, Italy, Spain, the UK, Japan, Brazil, China, and India. Key Topics Covered: List of Tables List of Figures Introduction Industry Overview Unmet Needs Market Opportunity Analysis Market Drivers and Barriers Competitive Assessment Pipeline Assessment Clinical Trial Analysis Current and Future Players Market Outlook Appendix Companies Mentioned Argon Medical Devices Boston Scientific Cardinal Health CareFusion Corporation Cook Medical C. R. Bard Devicor Medical Products DTR Medical Gallini Medical Devices Hologic INRAD Intact Medical Corporation TSK Laboratory For more information visit http://www.researchandmarkets.com/research/qt...int_biopsy About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
MediPoint: Biopsy Devices - Current and Future Players Report
M2 - Tue Mar 04, 2:34AM CST
Research and Markets (http://www.researchandmarkets.com/research/t5nxz6/medipoint_biopsy) has announced the addition of the "MediPoint: Biopsy Devices - Current and Future Players" report to their offering. Cancer is the uncontrolled growth of abnormal cells in the body. It can affect numerous organs and tissues of the body. When a patient is suspected of having a particular type of cancer, a biopsy procedure is performed to extract a target tissue sample for histological analysis. This intervention typically provides a definitive cancer diagnosis for the patient. Given that these procedures play such an important role in the diagnostic pathway for various cancers, medical device manufacturers have worked to develop biopsy devices that maximize the volume and quality of the tissue samples, as well as decrease their negative impact on the patient's body. As seen with other medical device markets, less invasive biopsy techniques have entered the market and have established a new gold standard in many global regions. The report identifies and analyzes the key companies shaping and driving the global Biopsy Devices market. The report provides insight into the competitive Biopsy Devices landscape, including new companies entering the market and pipeline products in development. This report is built using data and information sourced from proprietary databases, secondary sources and primary research interviews and survey with leading cardiologists, with in-house analysis conducted by Our team of industry experts. Scope - Investigation of current and future market competition for Biopsy Devices. - Competitor assessment including device approval analysis. - Coverage of key market players and company profiles including business description, financial overview and SWOT analysis. - Strategic assessment of the device sector through market impact analysis, future market scenario and company analysis. - Direct quotes from Key Opinion Leaders (KOL) as well as cardiologists using Biopsy Devices devices in clinical practice. Key Topics Covered: List of Tables List of Figures Introduction Competitive Assessment Pipeline Assessment Current and Future Players Appendix Companies Mentioned Argon Medical Devices Boston Scientific Cardinal Health CareFusion Corporation Cook Medical C. R. Bard Devicor Medical Products DTR Medical Gallini Medical Devices Hologic INRAD Intact Medical Corporation TSK Laboratory For more information visit http://www.researchandmarkets.com/research/t5...int_biopsy About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
2013 Report on the International Biopsy Devices Market - Global Forecasts to 2018
M2 - Mon Jan 06, 6:20AM CST
Research and Markets (http://www.researchandmarkets.com/research/s3fbcm/biopsy_devices) has announced the addition of the "2013 Report on the International Biopsy Devices Market - Global Forecasts to 2018" report to their offering. For the purpose of this research, the international biopsy device market has also been segmented geographically into four regions, namely, North America, Europe, Asia and Rest of the World (RoW), and the respective market sizes and forecasts have been provided for each of these regions. A detailed qualitative analysis of the factors responsible for driving and restraining growth of the global biopsy devices market, and future opportunities is provided in the market overview section. This section also features a detailed market attractiveness analysis and Porter's five force analysis for the biopsy devices market. The competitive landscape section includes market share analysis of all the leading players in this market, for the year 2011. Some of the major players profiled in this report include Angiotech, C R Bard Inc., CareFusion Corporation, Devicor Medical Products Inc. and Hologic Inc. Key Topics Covered: 1 Preface 1.1 Report Description 1.2 Market Segmentation 1.3 Research Methodology 2 Executive Summary 3 Market Overview 3.1 Introduction 3.2 Market Drivers 3.3 Market Restraints 3.4 Market Opportunities 3.5 Porter's Five Forces Analysis 3.6 Market Attractiveness Analysis 4 Biopsy Devices Market, By Product Types 4.1 Introduction 4.2 Comparative Analysis: Biopsy Devices Market, By Product Types, 2011 & 2018 (Value %) 4.3 Needle-Based Biopsy Guns 4.4 Biopsy Needles 4.5 Biopsy Forceps 4.6 Biopsy Guidance Systems 4.7 Others 5 Biopsy Devices Market, By Geography 5.1 Comparative Analysis: Biopsy Devices Market, By Geography, 2011 & 2018 (Value %) 5.2 North America 5.3 Europe 5.4 Asia 5.5 Rest of the World 6 Competitive Landscape 7 Recommendations 8 Company Profiles Companies Mentioned: - Angiotech - Cardinal Health Inc. - Carefusion Corporation - C. R. BARD, Inc. - Devicor Medical Products, Inc. - DTR Medical - Hologic, Inc. - INRAD, Inc. - UK Biopsy For more information visit http://www.researchandmarkets.com/research/s3...sy_devices
IBC at SPIE Optics + Photonics 2013 Conference: White Paper Confirms Significant Cost Savings Using Beralcast(R) High Performance Alloys
Marketwire - Tue Sep 10, 8:03AM CDT
IBC Advanced Alloys Corp. (TSX VENTURE: IB)(OTCQX: IAALF) ("IBC" or the "Company"
released a white paper and presented a preliminary analysis of IBC's proprietary Beralcast(R) alloys as a cost-effective high performance alloy solution for advanced optical applications at the recent SPIE Optics + Photonics 2013 Conference in San Diego. The white paper confirmed that significant cost savings are potentially achievable with the mirror design selected for the study. Inrad Optics, Inc. Reports Financial Results For Second Quarter And Six Months 2013
PR Newswire - Mon Aug 19, 7:00AM CDT
Inrad Optics, Inc. (OTC Bulletin Board: INRD) has reported its consolidated financial results for its second quarter and six months ended June 30, 2013.
IV Fluid Transfer Devices Report - Products, Players, Markets and Opportunities
M2 - Wed Jun 26, 3:38AM CDT
Research and Markets (http://www.researchandmarkets.com/research/fnpmtc/iv_fluid_transfer) has announced the addition of the "IV Fluid Transfer Devices Products, Players, Markets and Opportunities" report to their offering. Intravenous drug administration is one of the most common therapeutic procedures that patients in a hospital setting are likely to receive. Yet the lack of standardization among the various components, elements and steps that a caregiver must navigate to successfully execute a drug intravenously have - according to several recent studies - contributed to medication errors and risks to patient safety. IV drug administration was once provided to patients only in clinical settings. However, technology developments and a greater emphasis on cost containment over the last 30 years have prompted a shift to providing this therapy in alternate settings, including the home. Highlights: - Analyzes the global market for IV fluid transfer devices market segments, and assesses the probable market
Inrad Optics Installs New Plasma Assisted Deposition System
PR Newswire - Tue Apr 23, 10:55AM CDT
Inrad Optics, Inc. (OTBB: INRD) has advanced its thin film coating capabilities with the installation of a new plasma assisted e-beam vacuum deposition system. The new coating system employs high-density plasma technology to dramatically enhance the quality of thin films by improving a wide variety of mechanical and optical properties. Its large 96-inch chamber also significantly increases Inrad Optics' capacity and allows the company to handle parts up to 1 meter in diameter.
Biopsy Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018
M2 - Thu Apr 04, 8:34AM CDT
Research and Markets (http://www.researchandmarkets.com/research/5smfv8/biopsy_devices) has announced the addition of the "Biopsy Devices Market (Disposable & Reusable Needles, Hot & Cold Forceps, Needle-based Biopsy Guns, VAB, CNB, FNAB Devices, Guidance Systems) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018" report to their offering. Biopsy devices are growing in importance due to the increasing global incidence of cancer and the growing willingness of patients to spend money on these medical procedures. This report studies the market for biopsy devices in five different product segments, namely, needle-based biopsy guns, biopsy needles, biopsy forceps, biopsy guidance systems and other biopsy devices. Each of these segments has been further divided into sub-segments by type. Market size estimates and forecasts for the period 2010 to 2018 have been given for each of the segments and sub-segments, in terms of USD million, using 2011 as the base year. The CAGR (%) of eac
Inrad Optics, Inc. Announces FY 2012 Financial Results
PR Newswire - Wed Apr 03, 3:18PM CDT
Inrad Optics, Inc. (the "Company"
(OTC Bulletin Board: INRD) has released its consolidated financial results for the year ended December 31, 2012. Inrad Optics, Inc. Announces Reduction In Work-force
PR Newswire - Thu Mar 07, 12:30PM CST
Optical component and crystalline device manufacturer Inrad Optics, Inc. (OTCBB: INRD) announced a combined work-force reduction of eight employees at its Northvale, NJ and Sarasota, FL production facilities effective March 1, 2013. This represents a reduction of approximately 9%. The Company has undertaken these steps to reduce costs and improve efficiencies within the organization. The move is expected to save the Company $658,000 annually including estimated fringe benefit costs and additional savings from reduced work hours for selected employees. This excludes one-time severance and accrued vacation payments to terminated employees of approximately $105,000 which the Company expects to pay in the first quarter ending March 31, 2013.
